Laponis Adam 4
4 · Twist Bioscience Corp · Filed May 26, 2026
Research Summary
AI-generated summary of this filing
Twist Bioscience (TWST) CFO Adam Laponis Sells 2,019 Shares
What Happened Adam Laponis, Chief Financial Officer of Twist Bioscience (TWST), sold 2,019 shares in an open-market transaction on May 21, 2026 at $53.26 per share, for proceeds of $107,526. This sale was a "sell-to-cover" tied to tax withholding for vested restricted stock units (RSUs), not a discretionary investment decision.
Key Details
- Transaction date and price: 2026-05-21, 2,019 shares at $53.26 each.
- Total proceeds: $107,526.
- Shares owned after transaction: not specified in the provided filing.
- Footnote: The sale was mandated to satisfy tax withholding on RSU vesting (sell-to-cover per issuer election).
- Filing timeliness: Form filed 2026-05-26 (five days after the transaction); Form 4s are typically due within two business days, so this appears to be a late filing.
Context Sell-to-cover transactions are routine administrative sales to cover tax obligations when equity awards vest and do not necessarily reflect the insider's view of the company. Purchases by insiders are generally more indicative of bullish sentiment; mandated sales like this are common and driven by tax mechanics rather than trading intent.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-05-21$53.26/sh−2,019$107,526→ 116,675 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.